Evaluation of circulating cell-free DNA in cholestatic liver disease using liver-specific methylation markers

RT @MayoClinicGIHep: #ScholarlySunday--@DrLazaridis">@DrLazaridis?src=hashtag_click">#ScholarlySunday--@DrLazaridis #cfDNA offers promise as a non-invasive liquid-biopsy to evaluate liver-specific cell-d…

#ScholarlySunday--@DrLazaridis">@DrLazaridis?src=hashtag_click">#ScholarlySunday--@DrLazaridis #cfDNA offers promise as a non-invasive liquid-biopsy to evaluate liver-specific cell-death in patients with cholestatic #liver diseases https://t.co/0AiEEIAmwN @BMC_series

RT @DrLazaridis: Using cell-free DNA approaches in PSC and PBC. A promising method for assessing disease progression. This is just a starti…

RT @DrLazaridis: Using cell-free DNA approaches in PSC and PBC. A promising method for assessing disease progression. This is just a starti…